Pharmaceutical Technology, Aug 2, 2014 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Aug 2, 2014
Cover Story
Pharma Investments Reflect Key Industry Trends
By Cynthia Challener, PhD
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Bioavailability Enhancement with Lipid-Based Drug-Delivery Systems
By Adeline Siew, PhD
Experts from Capsugel and Catalent discuss the rationale of using lipid-based formulations to improve the oral bioavailability of poorly soluble drugs.
Peer-Reviewed Research
Comparing Manufacturing Process Options
By Simon D. Fraser , Diana Dujmovic , Johannes G. Khinast
A techno-economic profiling method supports pharmaceutical process development by helping identify the best manufacturing approach.
Supply-Chain Security
Implementing Supply-Chain Security
By Jennifer Markarian
The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.
Industry Takes Steps to Prevent Counterfeit Drugs
By Jennifer Markarian
The fight against counterfeit drugs is an international effort, as exemplified by the ?Fight the Fakes? campaign.
Complying with Revised Weighing Guidelines
By Joanne Ratcliff, PhD , Martin Huber
The latest revisions to the USP General Chapters >41< Balances and >1251< Weighing on an Analytical Balance aim to ensure weighing accuracy and eliminate unnecessary overtesting by simplifying previous descriptions and reflecting current state-of-the-art weighing practices.
API Synthesis & Manufacturing
Risk Reduction Top Driver for Biopharmaceutical Raw Material Development
By Cynthia Challener, PhD
Customers are looking to reduce risk, increase performance, and optimize productivity.
Featured Content
Reducing False Out-of-Control Signals
By Ronald D. Snee
Control charts that are properly constructed and maintained prevent false out-of-control signals and provide a useful method for monitoring a process.
Regulatory Watch
Changes and Challenges for Generic Drugs
By Jill Wechsler
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Outsourcing Outlook
Relationship-building at Top of Mind for Clients
By Eric Langer
Annual study shows CMO technical expertise is not enough.
From The Editor
A Silver Milestone for Drug Development
By Rita Peters
Pharmaceutical Technology Europe marks 25 years of drug-development advances.
Product Spotlight
HMI Software Improves Manufacturing Performance
Schneider Electric's Wonderware InTouch HMI software is operable on embedded versions of Microsoft Windows operating systems.
Wireless LAN Product Lines Expand Portfolio
The Scalance W761-1 RJ45 access point and the Scalance W721-1 RJ45 client module from Siemens provide an affordable solution for wireless machine networking from inside a cabinet.
Computer Aided Engineering Software Increases Productivity
CD-adapco's STAR-CCM+ v9.04 simulation tool allows users to reduce overall time-to-solution.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here